Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endpoint”

594 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 594 results

Not applicableStudy completedNCT03740971
What this trial is testing

Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke

Who this might be right for
Stroke
General Hospital of Shenyang Military Region 1,800
Not applicableStudy completedNCT03174535
What this trial is testing

Risk Assessment Model for Ischemic Stroke Endpoint Events

Who this might be right for
Ischemic Stroke
China Academy of Chinese Medical Sciences 3,000
Not applicableLooking for participantsNCT07635394
What this trial is testing

Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome (IBS)
Beijing Tiantan Hospital 258
Not applicableStudy completedNCT03324503
What this trial is testing

Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
Celgene 8
Large-scale testing (Phase 3)Study completedNCT05295173
What this trial is testing

R-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Who this might be right for
Acute Ischemic Stroke
Angde Biotech Pharmaceutical Co., Ltd. 1,412
Large-scale testing (Phase 3)Study completedNCT05657470
What this trial is testing

Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK)

Who this might be right for
Stroke, Ischemic
General Hospital of Shenyang Military Region 80
Testing effectiveness (Phase 2)UnknownNCT03145961
What this trial is testing

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 208
Large-scale testing (Phase 3)Study completedNCT02195986
What this trial is testing

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Who this might be right for
Atrophic Vaginitis
Mylan Pharmaceuticals Inc 366
Large-scale testing (Phase 3)WithdrawnNCT02229175
What this trial is testing

Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
University of California, San Francisco
Post-approval studies (Phase 4)Not Yet RecruitingNCT07490509
What this trial is testing

Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

Who this might be right for
AbemaciclibAbemaciclib-related DiarrheaBreast Cancer
Poitiers University Hospital 235
Testing effectiveness (Phase 2)Study completedNCT04516993
What this trial is testing

CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II

Who this might be right for
Stroke
Huashan Hospital 224
Large-scale testing (Phase 3)Study completedNCT00985322
What this trial is testing

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis

Who this might be right for
Left Ventricular HypertrophyHypertension
Mario Negri Institute for Pharmacological Research 269
Not applicableLooking for participantsNCT07362875
What this trial is testing

Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy
Wake Forest University Health Sciences 75
Testing effectiveness (Phase 2)Study completedNCT02394730
What this trial is testing

Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints

Who this might be right for
HIV
Kirby Institute 65
Very early researchNot Yet RecruitingNCT07806136
What this trial is testing

Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipient
Virginia Commonwealth University 20
Not applicableUnknownNCT02929836
What this trial is testing

Catheter Ablation of Longstanding Persistent Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Shanghai Chest Hospital 450
Not applicableStudy completedNCT04745000
What this trial is testing

Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension

Who this might be right for
Hypertension;Pulmonary;Primary
University of Colorado, Denver 43
Early research (Phase 1)Study completedNCT02260492
What this trial is testing

Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma

Who this might be right for
Asthma
Oriel Therapeutics 879
Not applicableStudy completedNCT05921734
What this trial is testing

Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation

Who this might be right for
Atrial FibrillationCathter AblationEndpoint
Shanghai Chest Hospital 480
Large-scale testing (Phase 3)Study completedNCT02942576
What this trial is testing

Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 632
Next Page